Harmony Biosciences Holdings, Inc.
HRMY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $145,493 | $128,853 | $181,468 | $34,597 |
| Dep. & Amort. | $24,112 | $24,359 | $25,048 | $21,078 |
| Deferred Tax | -$29,298 | -$13,419 | $0 | $0 |
| Stock-Based Comp. | $42,602 | $31,705 | $26,905 | $16,105 |
| Change in WC | -$7,321 | $35,035 | -$6,891 | $2,186 |
| Other Non-Cash | $44,233 | $12,854 | -$82,064 | $24,591 |
| Operating Cash Flow | $219,821 | $219,387 | $144,466 | $98,557 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,153 | -$312 | -$172 | -$298 |
| Net Acquisitions | -$33,069 | -$36,967 | $0 | $0 |
| Inv. Purchases | -$105,289 | -$127,469 | $0 | $0 |
| Inv. Sales/Matur. | $98,527 | $118,309 | $0 | $0 |
| Other Inv. Act. | -$26,500 | $0 | -$141,660 | -$100,000 |
| Investing Cash Flow | -$67,484 | -$46,439 | -$141,832 | -$100,298 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$15,000 | -$1,250 | -$2,000 | -$500 |
| Stock Issued | $6,501 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$100,000 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,497 | -$4,302 | $8,841 | $7,919 |
| Financing Cash Flow | -$10,996 | -$105,552 | $6,841 | $7,419 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $141,341 | $67,396 | $9,475 | $5,678 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $311,930 | $244,534 | $235,059 | $229,381 |
| End Cash | $453,271 | $311,930 | $244,534 | $235,059 |
| Free Cash Flow | $218,668 | $219,075 | $144,294 | $98,259 |